2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT Maribavir - Hematologic Malignancy | Phase 3 | Recruiting | Ruijin Hospital | 218 | 2026-02-28 | 2026-04-06 |
| An Extension Study for Patients Previously Enrolled in Studies With Pelabresib Pelabresib - Hematologic Malignancy, Solid Tumor | Phase 3 | Recruiting | Novartis Pharmaceuticals | 50 | 2024-08-13 | 2026-06-11 |
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms (2) · Neoplasms by Site (2)
Novartis Pharmaceuticals (1) · Ruijin Hospital (1)
Belgium (1) · China (1) · Italy (1) · Netherlands (1) · United Kingdom (1) · United States (1)
2023 (1)